The Effectiveness of the Use of Methods of Collapse Therapy and Valvular Bronchoblocation as Preoperative Preparation in Patients with Pulmonary Tuberculosis
https://doi.org/10.52420/umj.23.6.58
EDN: LLZOKH
Abstract
An important area in the work of the TB service is the search for integrated approaches in the treatment of patients with pulmonary tuberculosis. One of these approaches is the widespread use of methods of artificial pneumoperitoneum and endobronchial valvular bronchoblocation. The active use of surgical treatment can also be an effective technique.
The aim of the work is to study the effectiveness of the use of methods of artificial pneumoperitoneum and endobronchial valvular bronchoblocation as preoperative preparation in patients with pulmonary tuberculosis.
Materials and methods. The study included 295 patients: group 1 — patients treated with artificial pneumoperitoneum and endobronchial valvular bronchoblocation (n = 201); group 2 consisted patients who did not use these methods (n = 94).
Results. Operations with the smallest volume were significantly more often performed in patients of group 1a (34.8 %), compared with group 1b and group 2a (p1a–1b = 0.016, p1a–2a = 0.014). Large-volume surgery was significantly more often performed in patients of group 2 (41.1 %, p1a–2a = 0.028).
Discussion. The use of artificial pneumoperitoneum and endobronchial valvular bronchoblocation helps to reduce the volume of surgical intervention. Thus, in the group of patients after effective endobronchial valvular bronchoblocation and artificial pneumoperitoneum, lung resection within 1–2 segments was significantly more often used; whereas in the group of patients who did not use artificial pneumoperitoneum and endobronchial valvular bronchoblocation techniques, large-scale surgical interventions were more often resorted to.
Conclusion. The use of artificial pneumoperitoneum and endobronchial valvular bronchoblocation helps to increase the effectiveness of treatment and reduce the volume of surgery, preventing significant damage to the loss of lung tissue.
Keywords
Supporting agencies: The article was prepared in the course of work on the research topic of the Central Tuberculosis Research Institute of No. 122041100206-7 “Innovative Approaches to the Diagnosis and Treatment of Patients with Drug-Resistant Tuberculosis of the Respiratory System, Including with Concomitant Pathology”.
About the Authors
N. V. Chumovatov
Central Tuberculosis Research Institute
Russian Federation
Competing Interests:
Russian Federation
Nikita V. Chumovatov — Candidate of Sciences (Medicine), Researcher of the Department of Phthisiology
Moscow
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest.
N. A. Chernyh
Central Tuberculosis Research Institute
Russian Federation
Competing Interests:
Russian Federation
Natalya A. Chernyh — Candidate of Sciences (Medicine), Senior Researcher of the Department of Phthisiology
Moscow
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest.
O. G. Komissarova
Central Tuberculosis Research Institute; N. I. Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Oksana G. Komissarova — Doctor of Sciences (Medicine), Associate Professor, Deputy Director for Scientific and Medical Work, Central Tuberculosis Research Institute; Professor of the Department of Phthisiology, N. I. Pirogov Russian National Research Medical University
Moscow
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest.
V. V. Romanov
Central Tuberculosis Research Institute
Russian Federation
Competing Interests:
Russian Federation
Vladimir V. Romanov — Doctor of Sciences (Medicine), Professor, Head of the Department of Phthisiology
Moscow
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest.
References
1. Chumovatov NV, Komissarova OG, Chernyh NA. Modern approaches to treatment of patients with multi-drug resistant tb using novel TB drugs. CTRI Bulletin. 2023;7(1):5–12. (In Russ.). DOI: https://doi.org/10.57014/2587-6678-2023-7-1-5-12.
2. Vasilyeva IA, Testov VV, Sterlikov SA. Tuberculosis situation in the years of the COVID-19 pandemic — 2020– 2021. Tuberculosis and Lung Diseases. 2022;100(3):6–12. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2022-100-3-6-12.
3. Pasechnik OA, Zimoglyad AA, YarusovaIV, Vitriv SV, Blokh AI. Tuberculosis with multiple and broad drug resistance in the Omsk region: Main trends and characteristics. Pacific Medical Journal. 2018;4(74):95–100. (In Russ.). DOI: https://doi.org/10.17238/PmJ1609-1175.2018.4.95-100.
4. Sterlikov SA, Rusakova LI, Obukhova OV. Methodology of cost estimation for the detection, diagnosis and treatment of tuberculosis with multiple and broad drug resistance. Health Care Manager. 2019; (1):56–63. (In Russ.). EDN: https://www.elibrary.ru/ponnpe.
5. Vasilyeva IA, Samoylova AG, Zimina VN, Lovacheva OV, Abramchenko AV. Chemotherapy for tuberculosis in Russia — the story continues. Tuberculosis and Lung Diseases. 2023;101(2):8–12. (In Russ.). DOI: https://doi.org/10.58838/2075-1230-2023-101-2-8-12.
6. Oelofse S, Esmail A, Deacon A, Konradi F, Olayanju O, Ngubane N, et al. Pretomanid with bedaquiline and linezolid in drug-resistant tuberculosis: Comparison of potential cohorts. The International Journal of Pulmonary Tuberculosis. 2021;25(6):453–460. DOI: https://doi.org/10.5588/ijtld.21.0035.
7. Balasanyants GS. Experience of using bedaquiline in the multimodality therapy of tuberculosis patients with concurrent HIV infection. Tuberculosis and Lung Diseases. 2017;95(9):49–54. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2017-95-9-49-54.
8. Egorov EV, Naumova TA, Gayda AI, Dadasheva KhB, Lovacheva OV. Comprehensive treatment of generalized tuberculosis with endobronchial valves. Tuberculosis and Lung Diseases. 2024;102(2):70–76. (In Russ.). DOI: https://doi.org/10.58838/2075-1230-2024-102-1-70-76.
9. Popova LA, Shergina ЕA, Lovacheva ОV, Shabalina IYu, Bagdasaryan TR, Sidorova NF. Change in lung function early aſter endoscopic bronchialvalve placementin patients with chronic cavitary tuberculosis. Pulmonologiya. 2018;28(3):332–340. (In Russ.). DOI: https://doi.org/10.18093/0869-0189-2018-28-3-332-340.
10. Yerimbetov K, Bektursinov B, Ibrayev Zh, Imakhayev A, Turgumbayev B, Aubakirov Ye, et al. The effi-ciency of surgical treatment of pulmonary tuberculosis in patients with drug-resistant tuberculosis on the background of various chemotherapy regimens. Ftiziopul’monologiya. 2022;39(1):74–84. (In Russ.). DOI: https://doi.org/10.56834/26631504_2022_1_74.
11. Chumovatov NV, Komissarova OG, Chernyh NA, Romanov VV. The effectiveness of the use of collapse therapy methods and bronchoblocation in the complex treatment of a patient with multidrug resistance pathogen: Clinical observation. Ural Medical Journal. 2024;23(3):120–135. (In Russ.). DOI: https://doi.org/10.52420/umj.23.3.120.
12. Аbdullаev RYu, Komissаrovа OG, Chumаkovа ES, Odinets VS, Ergeshov AE. Hepatotoxic reactions during treatment of newly diagnosed patients with pulmonary multiple drug resistant tuberculosis. Tuberculosis and Lung Diseases. 2019;97(7):21–27. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2019- 97-7-21-27.
13. Garifullin ZR, Aminev ZK. Long-term results of surgical treatment of patients with drugresistant pulmonary tuberculosis. Kazan Medical Journal. 2009;90(5):695–699. (In Russ). EDN: https://www.elibrary.ru/lhqaap.
14. Sabirov ShYu, Rakhmanov ShA. Surgical treatment of pulmonary tuberculosis with multidrugresistant pathogen. Tuberculosis and Lung Diseases. 2015;6:128–129. (In Russ). EDN: https://www.elibrary.ru/ubilnb.
15. Asoyan GA, Lepekha LN, Sadovnikova SS, Tarasov RV, Aliev VK, Bagirov MA. Reduction of the risk of bronchopleural complications aſter pneumonectomy due to the use of intraoperative laser treatment of the stump of the main bronchus. Bulletin of the Medical Institute “REAVIZ” (Rehabilitation, Doctor and Health). 2022;12(6):78–85. (In Russ). DOI: https://doi.org/10.20340/vmi-rvz.2022.6.CLIN.6.
16. Skornyakov SN, Motus IYa, Kildyusheva EI, Medvinsky ID, Bazhenov AV, Savelyev AV. Surgery of destructive drug-resistant pulmonary tuberculosis. Tuberculosis and Lung Diseases. 2015;(3):15–20. (In Russ). EDN: https://www.elibrary.ru/tqbcqz.
17. Levin A, Sklyuev S, Felker I, Krasnov D, Tceymach E. Endobronchial valve treatment of destructive multidrug resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease. 2016;20(11):1539– 1545. DOI: https://doi.org/10.5588/ijtld.16.0033.
18. Popova LA, Shergina ЕА, Bagdasaryan TR, Chernykh NA, Sidorova NF, Lovacheva OV. Changes in ventilatory and gas exchange pulmonary functions when endobronchial valve block is effectively implanted to those with destructive pulmonary tuberculosis. Tuberculosis and Lung Diseases. 2018;96(11):35–44. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2018-96-11-35-43.
19. Аskalonova OYu, Tseymakh EA, Levin АV, Zimonin PE. Postponed treatment outcomes in patients with limited fibrous cavernous pulmonary tuberculosis with use of valve bronchial block. Tuberculosis and Lung Diseases. 2021;99(2):29–33. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2021-99-2-29-33.
20. Chernykh N, Zakharov A, Chumovatov N, Romanov V, Sivokozov I. Effectiveness of endoscopic lung volume reduction in the treatment for complicated fibrocavernous pulmonary tb in a patient with poorly controlled diabetes mellitus. CTRI Bulletin. 2022;(2):81–93. DOI: https://doi.org/10.7868/S2587667822020108.
21. Golubchikov PN, Kruk ЕА, Mishustin SP, Petrenko TI, Kudlay DA. Experience of treating extensive drug resistant tuberculosis patients including continuous use of bedaquiline, in Tomsk region: Immediate and postponed results. Tuberculosis and Lung Diseases. 2019;97(8):38–45. (In Russ.). DOI: https://doi.org/10.21292/2075-1230–2019-97-8-38-45.
22. Stavitskaya NV, Felker IG, Zhukova EM, Tlif АЕ, Doktorova NP, Kudlay DА. The multivariate analysis of the results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis. Tuberculosis and Lung Diseases. 2020;98(7):56–62. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2020-98-7-56-62.
23. Bobyreva MG, Belov SA, Sudnischikov VV, Pimenov NA, Pyatanova AN. Analysis of feasibility of surgical treatment in fibrous cavernous pulmonary tuberculosis patients in Primorskiy region. Tuberculosis and Lung Diseases. 2019;97(5):67–68. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2019-97-5-67-68.
24. Riskiyev A, Ciobanu A, Hovhannesyan A, Akopyan K, Gadoev J, Parpieva N. Characteristics and treatment outcomes of patients with tuberculosis receiving adjunctive surgery in Uzbekistan. International Journal of Environmental Research and Public Health. 2021;18(12):6541. DOI: https://doi.org/10.3390/ijerph18126541.
25. Omelchuk DE, Krasnov DV, Petrenko TI, BolshakovaIA, Kochneva AA. Postponed results of lung resections for disseminated fibrous cavernous tuberculosis. Tuberculosis and Lung Diseases. 2024;102(3):58–63. (In Russ). DOI: https://doi.org/10.58838/2075-1230-2024-102-3-58-63.
26. Romanova MI, Gayda AI, Abramchenko AV, Mozhokina GN, Lovacheva OV. Effectiveness of surgical treatment of patients with destructive pulmonary tuberculosis (meta-analysis). Tuberculosis and Lung Diseases. 2024;102(2):52–61. (In Russ.). DOI: https://doi.org/10.58838/2075-1230-2024-102-2-52-61.
27. Batyrshina YaR, Krasnov VA, Petrenko TI. Treatment outcomes of multiple and extensive drug resistant tuberculosis and efficacy of surgical resections in patients with high risk of unfavorable outcomes. Tuberculosis and Lung Diseases. 2016;94(5):28–34. (In Russ.). DOI: https://doi.org/10.21292/2075-1230-2016-94-5-28-34.
Supplementary files
Review
For citations:
Chumovatov NV, Chernyh NA, Komissarova OG, Romanov VV. The Effectiveness of the Use of Methods of Collapse Therapy and Valvular Bronchoblocation as Preoperative Preparation in Patients with Pulmonary Tuberculosis. Ural Medical Journal. 2024;23(6):58–69. (In Russ.) https://doi.org/10.52420/umj.23.6.58. EDN: LLZOKH
Views:
176
Email this article 